- Issuer ticker
-
ACXP
- Reported as of
-
20 Apr 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
22 Apr 2026, 16:18:28 UTC
Filing notes and source
Key filing fact
DELUCCIA ROBERT J filed Form 4 for Acurx Pharmaceuticals, Inc. (ACXP) on 22 Apr 2026.
Key facts
- This page summarizes DELUCCIA ROBERT J's Form 4 filing for Acurx Pharmaceuticals, Inc. (ACXP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 22 Apr 2026, 16:18.
Change
- Previous filing in this sequence was filed on 06 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001127423
Primary reporting owner
DELUCCIA ROBERT J
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACXP
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +37,100
- Change %
- Price
-
$0.000000*
- Shares after
- 37,100
- Date
- 20 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 37,100
- Exercise price
- $2.36
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote